These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38622730)
21. Editorial: Antimicrobial Stewardship in Low- and Middle-Income Countries. Gyssens IC; Wertheim HF Front Public Health; 2020; 8():617000. PubMed ID: 33344409 [No Abstract] [Full Text] [Related]
22. Antimicrobial resistance in low- and middle-income countries: current status and future directions. Sulis G; Sayood S; Gandra S Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545 [TBL] [Abstract][Full Text] [Related]
23. [Antibiotics in low- and middle-income countries]. Wertheim HF; Schultsz C Ned Tijdschr Geneeskd; 2014; 158():A8049. PubMed ID: 25248738 [TBL] [Abstract][Full Text] [Related]
24. Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis. Alsan M; Schoemaker L; Eggleston K; Kammili N; Kolli P; Bhattacharya J Lancet Infect Dis; 2015 Oct; 15(10):1203-1210. PubMed ID: 26164481 [TBL] [Abstract][Full Text] [Related]
25. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. Lucien MAB; Canarie MF; Kilgore PE; Jean-Denis G; Fénélon N; Pierre M; Cerpa M; Joseph GA; Maki G; Zervos MJ; Dely P; Boncy J; Sati H; Rio AD; Ramon-Pardo P Int J Infect Dis; 2021 Mar; 104():250-254. PubMed ID: 33434666 [TBL] [Abstract][Full Text] [Related]
26. Childhood vaccines and antibiotic use in low- and middle-income countries. Lewnard JA; Lo NC; Arinaminpathy N; Frost I; Laxminarayan R Nature; 2020 May; 581(7806):94-99. PubMed ID: 32376956 [TBL] [Abstract][Full Text] [Related]
27. Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries. Graells T; Lambraki IA; Cousins M; Léger A; Henriksson PJG; Troell M; Carson CA; Parmley EJ; Majowicz SE; Wernli D; Jørgensen PS Front Public Health; 2023; 11():1230848. PubMed ID: 37900049 [TBL] [Abstract][Full Text] [Related]
28. Benchmarking national action plans on antimicrobial resistance in eight selected LMICs: Focus on the veterinary sector strategies. Samuel F Orubu E; Sutradhar I; Zaman MH; Wirtz VJ J Glob Health; 2020 Dec; 10(2):020414. PubMed ID: 33110576 [TBL] [Abstract][Full Text] [Related]
29. Creating political commitment for antimicrobial resistance in developing countries. Bhatia R; Katoch VM; Inoue H Indian J Med Res; 2019 Feb; 149(2):83-86. PubMed ID: 31219072 [No Abstract] [Full Text] [Related]
30. Zoonotic sources and the spread of antimicrobial resistance from the perspective of low and middle-income countries. Olaru ID; Walther B; Schaumburg F Infect Dis Poverty; 2023 Jun; 12(1):59. PubMed ID: 37316938 [TBL] [Abstract][Full Text] [Related]
31. Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries. Nadimpalli M; Delarocque-Astagneau E; Love DC; Price LB; Huynh BT; Collard JM; Lay KS; Borand L; Ndir A; Walsh TR; Guillemot D; Clin Infect Dis; 2018 Mar; 66(6):963-969. PubMed ID: 29346620 [TBL] [Abstract][Full Text] [Related]
32. Antibiotic treatment for bacterial meningitis in children in developing countries. Fuller DG; Duke T; Shann F; Curtis N Ann Trop Paediatr; 2003 Dec; 23(4):233-53. PubMed ID: 14738571 [TBL] [Abstract][Full Text] [Related]
33. Investigating the impact of poverty on colonization and infection with drug-resistant organisms in humans: a systematic review. Alividza V; Mariano V; Ahmad R; Charani E; Rawson TM; Holmes AH; Castro-Sánchez E Infect Dis Poverty; 2018 Aug; 7(1):76. PubMed ID: 30115132 [TBL] [Abstract][Full Text] [Related]
34. Vaccines take a shot at antimicrobial resistance. Kingwell K Nat Rev Drug Discov; 2018 Apr; 17(4):229-231. PubMed ID: 29520094 [No Abstract] [Full Text] [Related]
35. Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis. Droz N; Hsia Y; Ellis S; Dramowski A; Sharland M; Basmaci R Antimicrob Resist Infect Control; 2019; 8():207. PubMed ID: 31893041 [TBL] [Abstract][Full Text] [Related]
36. Using Colonization to Understand the Burden of Antimicrobial Resistance Across Low- and Middle-Income Countries. Styczynski A; Herzig C; Luvsansharav UO; McDonald LC; Smith RM Clin Infect Dis; 2023 Jul; 77(Suppl 1):S70-S74. PubMed ID: 37406047 [TBL] [Abstract][Full Text] [Related]
37. Effect of vaccination on the use of antimicrobial agents: a systematic literature review. Doherty TM; Hausdorff WP; Kristinsson KG Ann Med; 2020 Sep; 52(6):283-299. PubMed ID: 32597236 [TBL] [Abstract][Full Text] [Related]
38. Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility. Sharma A; Singh A; Dar MA; Kaur RJ; Charan J; Iskandar K; Haque M; Murti K; Ravichandiran V; Dhingra S J Infect Public Health; 2022 Feb; 15(2):172-181. PubMed ID: 34972026 [TBL] [Abstract][Full Text] [Related]
39. The role of vaccines in combatting antimicrobial resistance. Micoli F; Bagnoli F; Rappuoli R; Serruto D Nat Rev Microbiol; 2021 May; 19(5):287-302. PubMed ID: 33542518 [TBL] [Abstract][Full Text] [Related]
40. Vaccination to Reduce Antimicrobial Resistance Burden-Data Gaps and Future Research. Tadesse BT; Keddy KH; Rickett NY; Zhusupbekova A; Poudyal N; Lawley T; Osman M; Dougan G; Kim JH; Lee JS; Jeon HJ; Marks F Clin Infect Dis; 2023 Dec; 77(Suppl 7):S597-S607. PubMed ID: 38118013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]